IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i15p8185-d607113.html
   My bibliography  Save this article

Assessing the Knowledge and Attitude toward COVID-19 Vaccination in Saudi Arabia

Author

Listed:
  • Heba M. Zahid

    (Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, P.O. Box 344, Madinah 42353, Saudi Arabia)

  • May A. Alsayb

    (Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, P.O. Box 344, Madinah 42353, Saudi Arabia)

Abstract

COVID-19 was declared a pandemic by the WHO in March 2020. The most promising strategy to control the pandemic was to develop a vaccine. However, vaccination hesitancy is a major threat to world public health. Understanding the reasons behind this hesitancy might help in developing encouragement strategies. This cross-sectional study aimed to assess the knowledge and attitude toward the COVID-19 vaccine in Saudi Arabia. A total of 1599 responses were received; the overall vaccine acceptancy was 79.2%. Age, sex, and nationality of participants significantly predicted the vaccination status. A significantly higher proportion of participants, who reported being vaccinated, or intended to receive the vaccine, stated that the COVID-19 infection is dangerous, or varies from person to person; the vaccine is safe, and think there is a definite need for the vaccine ( p < 0.001). The major encouragement factors to receive the vaccine were either confidence in the government decisions (54.8%), or the feeling of responsibility to stop the pandemic (48.7%), whereas the main discouraging factors were concerns about the insufficient clinical trials (11.4%), or the undiscovered side effects (11%). The results of this study indicate good acceptance toward the COVID-19 vaccine among residents of Saudi Arabia.

Suggested Citation

  • Heba M. Zahid & May A. Alsayb, 2021. "Assessing the Knowledge and Attitude toward COVID-19 Vaccination in Saudi Arabia," IJERPH, MDPI, vol. 18(15), pages 1-9, August.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:15:p:8185-:d:607113
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/15/8185/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/15/8185/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Smriti Mallapaty & Ewen Callaway, 2021. "What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine," Nature, Nature, vol. 592(7852), pages 15-17, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:15:p:8185-:d:607113. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.